Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

68.4900 EUR 0.8700 1.29%

As of 12:35:00 ET on 03/27/2015.

Snapshot for UCB SA (UCB)

Open: 67.9500 Day's Range: 67.5000 - 68.6100 Volume: 243,579
Previous Close: 67.6200 52wk Range: 54.5300 - 75.6200 1-Yr Rtn: +20.15%

Stock Chart for UCB

No chart data available.
  • UCB:BB 68.4900
  • 1D
  • 1M
  • 1Y
67.6200
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) 114.1500
Estimated P/E(12/2015) 35.1953
Relative P/E vs. BEL20 2.9992
Earnings Per Share (EUR) (ttm) 0.6000
Est. EPS (EUR) (12/2015) 1.9460
Est. PEG Ratio 1.5236
Market Cap (M EUR) 13,321.69
Shares Outstanding (M) 194.51
30 Day Average Volume 353,265
Price/Book (mrq) 2.6633
Price/Sale (ttm) 4.4424
Dividend Indicated Gross Yield 1.55%
Cash Dividend (EUR) 0.7950
Dividend Ex-Date
5 Year Dividend Growth 2.48%
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Jean-Christophe TellierChief Executive OfficerBharat TewarieChief Marketing Ofcr
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil